Top exec at publishing giant Relx held talks with investors to ditch UK listing for New York
But Nick Luff, chief financial officer at the £72billion group, denied there were any imminent plans to relocate.
The US is one of the largest markets for a firm that provides products for lawyers, scientists, medical professionals and bankers.
It also owns medical journal The Lancet and an exhibitions arm, which runs book convention Comic Con.
Relx reported a pre-tax profit of £1.52billion for the first half, up from £1.45billion in 2024.
Sales rose 7 per cent to £4.7billion on the back of strong demand for products that use generative AI.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
3 days ago
- The Independent
The small menu change that could make people healthier
A study by Liverpool University, published in The Lancet Public Health, found that salt warning labels on restaurant menus effectively encourage healthier food choices among consumers. The research, described as the "strongest evidence to date," indicated that these labels discourage the selection of high-salt options. In an online trial, labels reduced salt ordered by 0.26g per meal, while a real-world trial in a Liverpool restaurant saw a reduction of 0.54g per meal. The warning labels alert diners to dishes exceeding 50 per cent of the recommended UK daily salt limit of 6g and were effective across all age, sex, and education levels. Experts, including the study's lead author, Dr Rebecca Evans and Sonia Pombo from Action on Salt, highlighted the potential of such labelling policies to significantly improve public health and called for salt reduction to be central to UK food policy.
The Independent
3 days ago
- The Independent
Salt warnings on restaurant menus can encourage healthier choices, study finds
Salt warnings on restaurant menus can encourage consumers to make healthier choices, a first study into the initiative has suggested. Researchers have the 'strongest evidence to date' that UK consumers see warnings on menus to be effective in discouraging them from ordering options that are high in salt, according to the study by Liverpool University published in The Lancet Public Health. Salt warning labels included in the study alerted consumers to dishes exceeding 50% of the recommended UK daily salt limit of 6g. In an online trial with 2,391 UK adults, salt warning labels were perceived by participants as effective in discouraging selection of high-salt items and reduced salt ordered by 0.26g per meal. In a real-world trial at a Liverpool restaurant with 454 participants, labelled menus prompted greater awareness of salt content when ordering and reduced the salt ordered by 0.54g per meal. Across both trials, labels were found to be equally effective regardless of age, sex or education level. Dr Rebecca Evans, the study's lead author, said: 'Our study has found that salt warning labels on menus help people make healthier choices. 'Given that excess salt intake is a leading cause of diet-related disease, this kind of labelling policy could play a vital role in improving population health. 'This study demonstrates that even small nudges at the point of purchase can encourage healthier choices.' The research team said the study was the first real-world randomised controlled trial globally to evaluate salt labelling in a full-service restaurant environment. Sonia Pombo, from Action on Salt, said: 'This important new study adds to the growing evidence that clear and visible salt warning labels on menus can positively influence consumer choices and reduce salt intake. 'Eating out is no longer an occasional indulgence – it's a routine part of daily life. Yet many meals are loaded with salt, often without our knowledge or consent. 'If we're serious about protecting public health and saving lives, salt reduction must be front and centre of the UK's food policy agenda.'
Daily Mail
3 days ago
- Daily Mail
Experts pinpoint cause of surging rates of liver cancer - as cases surge in under 50s with numbers set to DOUBLE by 2050
Liver cancer is on course to become a far bigger global health crisis—particularly among younger adults—with cases expected to double by 2050, experts have warned. Once seen as a disease affecting mainly older people with hepatitis infections or alcohol dependency, liver cancer is now increasingly being diagnosed in people in their 30s and 40s. A major new analysis published in The Lancet links this shift to the rise in obesity and related liver conditions such as MASLD (metabolic dysfunction-associated steatotic liver disease). The report projects that the number of new liver cancer cases worldwide will jump from 870,000 in 2022 to 1.52 million by 2050, while annual deaths from the disease are set to rise from 760,000 to 1.37 million over the same period. Experts say one of the fastest-growing causes is MASH (metabolic dysfunction-associated steatohepatitis), a severe form of fatty liver disease tied to obesity and metabolic dysfunction. The proportion of liver cancers linked to MASH is expected to more than double, from 5 per cent in 2022 to 11 per cent in 2050. The number of cases caused the most common cause of the deadly disease—the hepatitis B virus—are set to decline. Similarly, cases caused by the hepatitis C virus are also expected to decline proportionately. However, the number of cases caused by obesity and alcohol are predicted to rise over the same time period. Specifically, over a fifth of liver cancer cases will be caused by alcohol by the year 2050. Meanwhile, one in ten cases will be caused by a severe form of MASLD—formerly known as fatty liver disease. This condition occurs when fat builds up in a person's liver, and is closely linked to obesity and type 2 diabetes. The team of researchers, from Hong Kong, highlighted that 60 per cent of cases of the deadly disease are preventable. On their findings, the researchers said they indicate that preventative measures need to be taken for liver cancer, which is also known as hepatocellular carcinoma. The main treatment for MASLD is eating a balanced diet, being physically active and potentially losing weight. 'Liver cancer is a growing health issue around the world,' said Professor Jian Zhou, chairman of the Commission from Fudan University in China. 'It is one of the most challenging cancers to treat, with five-year survival rates ranging from approximately 5 to 30 per cent. 'We risk seeing close to a doubling of cases and deaths from liver cancer over the next quarter of a surgery without urgent action to reverse this trend.' They study's lead author, Professor Stephen Chan, from the Chinese University of Hong Kong, added: 'There is a huge opportunity for countries to target these risk factors, prevent cases of liver cancer and save lives.' Commenting on the study, Pamela Healy, chief executive of the British Liver Trust, said: 'Liver is the fastest rising cause of cancer death in the UK, and just 13 per cent of people diagnosed will survive for five years or more.' 'We know that the biggest risk factors are having pre-existing liver cirrhosis or viral hepatitis, and this new analysis highlights that MASLD, also known as fatty liver disease, is expected to be linked to an increasing number of cases.' Liver cirrhosis is a progressive disease that can lead to live failure if left untreated—which is when the organ has permanent scarring due to long-term damage. 'As well as improving early detection through surveillance of people with cirrhosis, it is essential that we tackle these underlying causes and prioritise public health,' he added. 'By supporting people to maintain a healthy weight, cut down on alcohol and get tested and treated for hepatitis, we can prevent many cases of liver cancer and save lives.' In the UK, there has been a strong sense of urgency to tackle the UK's growing obesity crisis to alleviate pressures on the National Health Service. According to recent data, nearly two-thirds of adults in England are overweight, with an extra 260,000 people entering the category last year. Meanwhile, more than a quarter (26.5 per cent)—an estimated 14 million people—were classified as obese. Last month GPs allowed to prescribe weight loss jabs, collectively known as GLP-1s for the first time in a bid to tackle the crisis. An estimated 1.5 million people are now using weight loss jabs through the NHS or private clinics, while millions more are eligible. However, pharmacists today warned that growing demand may become unsustainable.
